Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment

This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.

書誌詳細
第一著者:	Shaikat, Mahdi Mubin
その他の著者:	Bin Naser, Dr. Iftekhar
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2023
主題:	CRISPR/Cas9 Genome editing Cancer Vectors Onco genes Cancer treatment Gene editing > Technological innovations. Cancer > Treatment
オンライン･アクセス:	http://hdl.handle.net/10361/18984

類似資料

CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
著者:: Maria, Amatul
出版事項: (2020)

A review on CRISPR-Cas system based applications in Oncology
著者:: Sadia, Mir
出版事項: (2022)

A review on CRISPR Technology as an Antiviral Tool
著者:: Srishti, Sanjida Ahmed
出版事項: (2023)

CRISPR/Cas9 genome editing to treat sickle cell disease
著者:: Ullah, Mohammad
出版事項: (2023)

A review paper on Nanotechnology based strategies in the treatment of cancer
著者:: Rahman, Samia
出版事項: (2022)

CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
著者:: Eva, Israt Ara Jannat
出版事項: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
著者:: Khondokar, Faiza
出版事項: (2022)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
著者:: Islam, Ankita
出版事項: (2022)

Biosimilar in lymphoma treatment
著者:: Tanisha, Mehrin Haque
出版事項: (2021)

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

Recent advancement on breast cancer detection and treatment
著者:: Rahman, Sanjida
出版事項: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Role of statins as antagonists of SPARC in gastric cancer
著者:: Shahmat, Rad
出版事項: (2019)

Targeting BRAFV600E in the treatment of CRC
著者:: Roja, Mashwiyat Samrin
出版事項: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
著者:: Hossain, Safa Binte
出版事項: (2019)

ক্যান্সার : মৃত্যু অবধারিত নয় /
著者:: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
著者:: Muntaha, Habibatul
出版事項: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
著者:: Rahman, Qazi Ashrafur
出版事項: (2018)

A comprehensive review on drug repurposing in cancer treatment
著者:: Sarkar, Onusree
出版事項: (2024)

Oncogenes: new targets in cancer treatment
著者:: Chowdhury, Waseka Shams
出版事項: (2020)

Qualitative classification of the breast cancer genome and clustering of the cancer gene network
著者:: Fatema, Kaniz, 等
出版事項: (2019)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

Potential of liposomes for the treatment of lung cancer- a review
著者:: Mim, Shanzida
出版事項: (2023)

Natural products and their combinatory effects in breast cancer treatment
著者:: Siddique, Md. Ayman
出版事項: (2021)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
著者:: Nahar, Kamrun
出版事項: (2023)

Analysis and comparison between the Genome of CRISPR bacteriophages
著者:: Muntaha, Mumtasin
出版事項: (2021)

A review on non-polyphenolic and terpenoid phytoconstituents with antioxidant and cytotoxic potential
著者:: Ahmed, Kazi Zeba
出版事項: (2021)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
著者:: Beruni, Sajid Mahmud Al
出版事項: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022)

Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
著者:: Nwabunwanne, Eze Uchenna
出版事項: (2022)

A review on recent advances in drugs for lung cancer treatment
著者:: Noor, Fouzia
出版事項: (2024)

A review on triple-negative breast cancer and its potential treatment
著者:: Niasa, Jannatul Ferdous
出版事項: (2023)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
著者:: Akter, Honufa
出版事項: (2024)

Microneedles in pain management of Cancer
著者:: Islam, Shafiqul
出版事項: (2022)

A review on less explored plants with anticancer activity
著者:: Al Nahid, Mohammed Tansen
出版事項: (2021)

A review on targeted therapies for lung cancer
著者:: Ashraf, Anushey
出版事項: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
著者:: Chakraborty, Anuradha
出版事項: (2024)